Productos farmacéuticos for Gerencia del Area de Atención Integrada de Guadalajara
Resolved
- Supplies
- Guadalajara, Castilla-La Mancha, España
- 2026/001437
Amount
€4,795,323.69
Tender for Pnsp 26/2026 adquisición de los principios activos vismodegiv, emicizumab, trastuzumab-emtansina, rituximab, ocrelizumab, pertuzumab+trastuzumab, atezolizumab, faricimab, vemurafenib (roche farma sa ) para la gai de guadalajara.
The tender identified with expedient 2026/001437 is related to the sector Supplies.
This tender is located in Guadalajara, Castilla-La Mancha, España, Not specified, Not specified.
The tender is classified under several CPV codes, including CPV, among others Productos farmacéuticos (No code: 33600000), Medicamentos diversos (No code: 33690000), among others.
All information updated in real time
Award criteria
Location:
Guadalajara, Castilla-La Mancha, EspañaStatus
ResolvedProcedure
Negotiated without publicationContract type
SuppliesPublication date
-Budget excluding taxes
€4,795,323.69Estimated contract value
€4,795,323.69Deadline
-Contract duration
-Extension
-Guarantee
-
View complete and updated information
To access all detailed and updated information about this tender, access our Tendios platform.
Access Tendios